Brookstone Capital Management Acquires 5,735 Shares of iShares Biotechnology ETF $IBB

Brookstone Capital Management grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 91.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,035 shares of the financial services provider’s stock after purchasing an additional 5,735 shares during the quarter. Brookstone Capital Management’s holdings in iShares Biotechnology ETF were worth $2,031,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Aster Capital Management DIFC Ltd acquired a new position in iShares Biotechnology ETF in the third quarter valued at approximately $1,907,000. Central Pacific Bank Trust Division grew its position in shares of iShares Biotechnology ETF by 296,500.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after buying an additional 14,825 shares during the period. SG Americas Securities LLC grew its position in shares of iShares Biotechnology ETF by 96.3% during the 3rd quarter. SG Americas Securities LLC now owns 28,569 shares of the financial services provider’s stock worth $4,125,000 after buying an additional 14,016 shares during the period. Florin Court Capital LLP bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $11,116,000. Finally, Viewpoint Capital Management LLC increased its stake in shares of iShares Biotechnology ETF by 1,532.1% in the 3rd quarter. Viewpoint Capital Management LLC now owns 12,730 shares of the financial services provider’s stock valued at $1,838,000 after acquiring an additional 11,950 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.4%

iShares Biotechnology ETF stock opened at $169.43 on Friday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $179.64. The firm’s fifty day moving average is $170.70 and its 200 day moving average is $164.77.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were paid a $0.1218 dividend. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.